MT Pharma
ActiveSummary
The computed 12-month bankruptcy probability of MT Pharma is 2.0% (moderate). The 2025 annual accounts show negative equity (-€47,943) and a net result of -€33,835. Its solvency ranks better than 11% of 12,482 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Connections & network
No directors read yet: 0 of 1 Gazette act processed.